"10.1371_journal.pone.0081950","plos one","2013-12-11T00:00:00Z","Mark-Oliver R√∂del; Christian Brede; Mareike Hirschfeld; Thomas Schmitt; Philippe Favreau; Reto St√∂cklin; Cora Wunder; Dietrich Mebs","Museum f√ºr Naturkunde Berlin, Leibniz Institute for Research on Evolution and Biodiversity, Berlin, Germany; Theodor-Boveri-Institute (Biocenter of the University), Department of Animal Ecology and Tropical Biology (Zoology III), W√ºrzburg, Germany; Atheris Laboratories, Bernex, Switzerland; Institute of Legal Medicine, University of Frankfurt, Frankfurt/M., Germany; Medizinische Klinik und Poliklinik II, Zentrum f√ºr Experimentelle Molekulare Medizin, W√ºrzburg, Germany; Ecological Networks, Biology, Technische Universit√§t Darmstadt, Darmstadt, Germany","Conceived and designed the experiments: MOR TS DM. Performed the experiments: MOR MH CB DM TS PF RS CW. Analyzed the data: MOR DM CB TS. Contributed reagents/materials/analysis tools: DM PF RS. Wrote the paper: MOR DM. Field work: MOR MH CB.","This is to certify that Reto Stocklin is the co-founder, owner, president and CEO of Atheris Laboratories, a biotechnology company working in the field of discovery of bio-active molecules from animal venoms and other natural origins. This does not alter the authors‚Ä≤ adherence to all the PLOS ONE policies on sharing data and materials of the work submitted, and the authors hereby certify that there is no financial or non-financial competing of interest for this manuscript to be published, in accordance with the PLOS ONE policies.","2013","12","Mark-Oliver R√∂del","MOR√",8,TRUE,3,8,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
